【我不是藥神】高藥價背後的黑幕 令人遺憾的電影結局
取材於真實故事的內地電影《我不是藥神》，7月5日上畫後迅速贏得口碑，截至7月23日上午，更斬獲逾28億元（人民幣．下同）票房佳績。電影以天價抗癌藥格列衛為切入點，講述一群底層中國人的自救與自贖，結尾以中國官方大刀闊斧的改革收官。影片上映之後，內地輿論討論不絕，連國務院總理李克強都就該片發聲，表態要求抗癌藥盡快減價，可見這部現實主義題材的電影，在當下中國有了超越其原有藝術和票房價值之處。
9.611 votes
11 votes
Editor's Choice
Dying to Survive
Jun 30, 2018|China|Comedy|Movie
Summary
Average middle-aged man Cheng Yong runs a store of dietary supplements. Depressed and divorced, he is offered a business opportunity to proxy-purchase medication from India to treat chronic myelogenous leukemia with aid from Lu Shouyi. As one thing leads to another, the profits multiply and the risks increase at every corner.
Genres
Comedy, DramaAward62 wins & 52 nominations
Share to
Videos
Related Articles
《我不是藥神》想活命，有什麼罪
中國電影《我不是藥神》強勢入圍第55屆金馬獎最佳劇情長片、最佳男主角等7個獎項，拍攝成本低，票房亮眼，已成為中國影史上，前五大票房神片。這部電影，到底在講什麼？
Film Review: ‘Dying to Survive’
Effectively a Sino version of 'Dallas Buyers Club,' this Chinese box-office sensation tells the fact-based story of an unlikely medical hero.
RATE THIS